IRWD icon

Ironwood Pharmaceuticals

227 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 80 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

59% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 51

Holders
227
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$15.6M
2 +$14.2M
3 +$13.3M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$11.1M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.6M

Top Sellers

1 -$30.5M
2 -$9.02M
3 -$8.35M
4
UBS Group
UBS Group
Switzerland
-$7.75M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.29M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$328K
127
$318K
128
$313K
129
$312K
130
$296K
131
$292K
132
$292K
133
$289K
134
$289K
135
$282K
136
$278K
137
$273K
138
$272K
139
$257K
140
$256K
141
$251K
142
$244K
143
$241K
144
$240K
145
$235K
146
$233K
147
$230K
148
$226K
149
$221K
150
$215K